Osaic Holdings
TYRA icon

Osaic Holdings’s Tyra Biosciences TYRA Stock Holding History

Osaic Holdings’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1K Sell
551
-637
-54% -$20.6K ﹤0.01% 5822
2025
Q4 		$31.2K Sell
1,188
-4
-0.3% -$73 ﹤0.01% 5562
2025
Q3 		$16.1K Buy
1,192
+183
+18% +$2.09K ﹤0.01% 6076
2025
Q2 		$9.65K Buy
1,009
+174
+21% +$1.65K ﹤0.01% 6174
2025
Q1 		$7.76K Buy
835
+813
+3,695% +$10.5K ﹤0.01% 5922
2024
Q4 		$306 Sell
22
-183
-89% -$3.32K ﹤0.01% 7118
2024
Q3 		$4.82K Buy
205
+171
+503% +$3.59K ﹤0.01% 6214
2024
Q2 		$544 Buy
+34
New +$585 ﹤0.01% 6963
2022
Q3 		– Sell
-1
Closed – – 7514
2022
Q2 		$0 Buy
+1
New +$8 ﹤0.01% 7603

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Osaic Holdings's TYRA Position: Q1 2026 in Review

Osaic Holdings reduced its Tyra Biosciences (TYRA) stake by 54% in Q1 2026, selling an estimated $20.6K and leaving 551 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5822.

Osaic Holdings first reported a position in TYRA in Q2 2022 and has held it in 9 quarters since. The position peaked at $31.2K in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Osaic Holdings held 551 shares of Tyra Biosciences worth $21.1K as of Q1 2026.
  • Osaic Holdings sold 637 Tyra Biosciences shares in Q1 2026, an estimated $20.6K.
  • Tyra Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5822 holding.
  • Osaic Holdings first reported a position in Tyra Biosciences in Q2 2022 and has held it in 9 quarters since.
  • Osaic Holdings's Tyra Biosciences position peaked at $31.2K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.